Blue Belt Technologies, Inc., a a Carnegie Mellon University spin off company developing surgical instruments for use in orthopaedic and neurosurgery procedures, closed a $2.4m private equity Series A round of financing.
The round was led by private investors including the Pittsburgh Life Sciences Greenhouse and Innovation Works and consisted of both new investments and the conversion of existing convertible notes.
As stated by Craig S. Markovitz, Chief Executive Officer of the Pittsburgh-based company, the funds will be used to finalize development and prepare for FDA submission of our core product, the Precision Freehand Sculptor, and will provide the resources necessary to prepare for full market release of our Orthopaedic and Neurosurgical products.
FinSMEs
30/09/2009